Free Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Colorado - United States Denver approves ban on all flavoured tobacco product sales ...
  • New Zealand Smokefree Environments Bill receives royal assent ...
  • Europe European Council adopts regulation to reduce and recycle packaging ...
  • Lithuania Reminder of tobacco display ban in convenience stores from 1st January ...
  • Indonesia Minimum retail price for tobacco and nic products set to increase ...
  • Sweden Snus product recalled due to exceeding permitted chemical limit ...
  • Vietnam National Assembly issues resolution formally requesting HTP ban ...
  • District of Columbia - United States Swedish Match to pay over $1m to resolve Zyn sale violation ...
  • Lithuania Parliament approves sanctions amendment for under-age sales ...
  • Japan Government plans to raise HTP excise duty ...
  • New Zealand Smokefree Environments Bill adopted in final reading ...
  • Russia Bill aims to ban sales of tobacco and nic products near universities ...
View all
News analysis

Drug Establishment Licence doesn’t let TJP Labs sell pouches in Canada – yet

Written by || 19th October 2022 || News analysis | Modern oral | Regulation and legislation | GeographiesCanada North America

A Canadian company says Health Canada’s decision to grant it a Drug Establishment Licence (DEL) is another step towards its goal of eventually selling nicotine pouches in Canada – though the department itself has confirmed to TobaccoIntelligence that it does not currently permit them to do so.

David Richmond-Peck, CEO of TJP Labs, said: “We carry a Health Canada drug licence which, we believe, would be a requirement for companies wanting to produce modern oral products in the future.”

Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber
Author default picture

TobaccoIntelligence

This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.